Anxiety treatment for Latino older adults with cancer and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the practicality and effectiveness of an anxiety treatment program specifically designed for Latino older adults with cancer and their caregivers. Participants must be 65 years or older, currently receiving or recently completed cancer treatment, and identify as Latino or Hispanic. The intervention focuses on managing anxiety related to cancer, with caregivers also involved in the process. The study will assess the impact of this program on anxiety levels among participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Older Adults with Cancer (OAC)

* As per medical record or self-report, is currently age 65 years or older
* As per medical record or self-report, currently receiving active cancer treatment OR is within eighteen months of completing active treatment which includes surgery, chemotherapy, radiation, and immunotherapy.
* As per self-report, identifies as Latino and/or Hispanic Ethnicity
* Per self-report, has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) age 40 or older who is willing and able to participate in the study ; if a patient does not have a primary informal caregiver or if the caregiver does not or cannot participate, but meets all other inclusion criteria they will be allowed to enroll in the study
* Scores ≥6 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
* Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:

  1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
  2. What is your preferred language for healthcare? (must respond English and/or Spanish)

Caregiver

* Per OAC report, is primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for the eligible OAC patient
* As per self-report, is age 40 years or older
* Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:

  1. How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
  2. What is your preferred language for healthcare? (must respond English and/or Spanish)

Exclusion Criteria:

OAC

* As per medical record or self-report, currently receiving psychotherapy
* As per medical record or self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
* As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
* Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
* Per research staff judgment and/or self-report, too ill or weak to complete study procedures
* Per medical record or self-report, receiving hospice care at the time of enrollment

Caregiver

* As per self-report, currently receiving psychotherapy
* As per self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
* As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
* Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
* Per research staff judgment and/or self-report, too ill or weak to complete study procedures

Where it's running

• Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
  Basking Ridge, New Jersey, United States Recruiting
• Memorial Sloan Kettering Monmouth (All Protocol Activities)
  Middletown, New Jersey, United States Recruiting
• Memorial Sloan Kettering Bergen (All Protocol Activities)
  Montvale, New Jersey, United States Recruiting
• Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
  Commack, New York, United States Recruiting
• Memorial Sloan Kettering Westchester (All Protocol Activities)
  Harrison, New York, United States Recruiting
• Memorial Sloan Kettering Cancer Center (All protocol activities)
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Kelly McConnell, PhD — Memorial Sloan Kettering Cancer Center
• Study coordinator: Kelly McConnell, PhD
• Email: mcconnek@mskcc.org
• Phone: 646-888-0026

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V

  This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.

  Recruiting at 13 sites Istituti Clinici Scientifici Maugeri SpA · Sciacca, Agrigento and 12 other locations · NCT07903298

• Diosmin/Hesperidin to Protect Kidneys in Platinum Chemotherapy

  This study tests whether taking diosmin and hesperidin helps protect the kidneys of cancer patients who are receiving platinum-based chemotherapy.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf · NCT07598214

• Tibetree topical herbal plasters for people using opioids for cancer pain

  This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07447856

• Heart Failure Carer Support Programme: Testing How to Deliver Help for Carers in the UK

  This trial tests a support program for informal carers of heart failure patients to see if it improves wellbeing for both carers and the patients they care for.

  Recruiting Queen's University, Belfast · Belfast and 4 other locations · NCT07373041

• SpadCare: digital home-care program for patients with PICC lines

  This program tests a smartphone app that teaches and remotely monitors adults with PICC lines who receive home infusions to help reduce catheter complications.

  Recruiting Fundacion Miguel Servet · Pamplona, Navarre · NCT06905119

• Comparing two methods of pain control after kidney surgery in cancer patients

  This study is testing two different ways to control pain after kidney surgery in cancer patients to see which method works better.

  Recruiting National Cancer Institute, Egypt · Cairo · NCT06889987

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.